NEW YORK, Dec. 11-Athersys has obtained exclusive rights to University of Minnesota stem cell technology in order to study stem cell differentiation and develop new therapeutics, the company said this morning.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.